Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab Meeting Abstract


Authors: Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
Abstract Title: Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 73s
Language: English
ACCESSION: WOS:000276606602064
PROVIDER: wos
Notes: Meeting Abstract: 1131 -- Source: Wos
MSK Authors
  1. Kimberly Nicole Feigin
    20 Feigin
  2. Sujata Patil
    381 Patil
  3. Clifford Hudis
    837 Hudis
  4. Larry Norton
    556 Norton
  5. Diana E Lake
    70 Lake
  6. Monica Nancy Fornier
    136 Fornier
  7. Tiffany A Traina
    153 Traina
  8. Shanu Modi
    132 Modi
  9. Stephanie Geneus
    6 Geneus